Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
International Journal of Medical Sciences
|
November 9, 2020
<i>HCK</i> can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
Xudong Zhu, Yixiao Zhang, Yang Bai, et al.
Annals of Translational Medicine
|
December 5, 2022
MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1
Sijie Feng, Yunkun Lu, Lisha Sun, et al.
Oncotarget
|
November 8, 2017
Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram
Caigang Liu, Yanlin Jiang, Xin Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2018
FSIP1 regulates autophagy in breast cancer
Caigang Liu, Lisha Sun, Jie Yang, et al.
Elife
|
July 28, 2021
Association of human breast cancer CD44<sup>-</sup>/CD24<sup>-</sup> cells with delayed distant metastasis
Xinbo Qiao, Yixiao Zhang, Lisha Sun, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2022
A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup>CD24<sup>-</sup> enriched breast cancer stem-like cells
Caigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Nature Communications
|
May 5, 2023
KK-LC-1 as a therapeutic target to eliminate ALDH<sup>+</sup> stem cells in triple negative breast cancer
Jiawen Bu, Yixiao Zhang, Sijin Wu, et al.
Elife
|
March 14, 2022
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
Yixiao Zhang, Lisha Sun, Haonan Li, et al.
Signal Transduction and Targeted Therapy
|
March 26, 2025
Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies
Chao Liu, Lisha Sun, Nan Niu, et al.
Science China. Life Sciences
|
July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
International Journal of Medical Sciences
|
November 9, 2020
<i>HCK</i> can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
Xudong Zhu, Yixiao Zhang, Yang Bai, et al.
Annals of Translational Medicine
|
December 5, 2022
MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1
Sijie Feng, Yunkun Lu, Lisha Sun, et al.
Oncotarget
|
November 8, 2017
Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram
Caigang Liu, Yanlin Jiang, Xin Gu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2018
FSIP1 regulates autophagy in breast cancer
Caigang Liu, Lisha Sun, Jie Yang, et al.
Elife
|
July 28, 2021
Association of human breast cancer CD44<sup>-</sup>/CD24<sup>-</sup> cells with delayed distant metastasis
Xinbo Qiao, Yixiao Zhang, Lisha Sun, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 4, 2022
A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44<sup>+</sup>CD24<sup>-</sup> enriched breast cancer stem-like cells
Caigang Liu, Yixiao Zhang, Jiujiao Gao, et al.
Nature Communications
|
May 5, 2023
KK-LC-1 as a therapeutic target to eliminate ALDH<sup>+</sup> stem cells in triple negative breast cancer
Jiawen Bu, Yixiao Zhang, Sijin Wu, et al.
Elife
|
March 14, 2022
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
Yixiao Zhang, Lisha Sun, Haonan Li, et al.
Signal Transduction and Targeted Therapy
|
March 26, 2025
Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies
Chao Liu, Lisha Sun, Nan Niu, et al.
Science China. Life Sciences
|
July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Page
of 11